SMO and atrial fibrillation: Both genetic ablation of Shh or Ihh in neonate mice and pharmacological inhibition of Smo in 8-week-old mice led to mild defects in AF and CEP [14, 16, 17], suggesting that Hh signaling may regulate AF/CEP growth and homeostasis at these stages.